Reuters logo
BRIEF-Matinas BioPharma says qtrly loss per share $0.04‍​
November 15, 2017 / 12:50 PM / 10 days ago

BRIEF-Matinas BioPharma says qtrly loss per share $0.04‍​

Nov 15 (Reuters) - Matinas Biopharma Holdings Inc-

* Matinas BioPharma reports 2017 third quarter financial results and provides corporate update

* Matinas BioPharma Holdings Inc - qtrly loss per share $0.04‍​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below